Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Alliacense Appoints Roy J. Maharaj Vice President, Licensing
I would like to be a fly on the wall and overhear Alliacense plans / objectives.  Would like to hear that over 800 companies have been notified.  That we are in active negotiations with over 100 company and we have an objective to establish a signing rate of 5 to 10 per week.  Goals.  Lets get 5 to 10 license deals a week or is that too low of an objective.
Share
New Message
Please login to post a reply